Examining the Utility of a Novel Neurologic Test in Patients With Obstructive Sleep Apnea: A Pilot Study

Purpose: To test the association between participant King-Devick Test (KDT) times and obstructive sleep apnea (OSA) severity and evaluate for improvement after continuous positive airway pressure (CPAP) treatment. Methods: Study dates January 30 to July 31, 2018. Patients were referred for initial e...

Full description

Bibliographic Details
Main Authors: Michael L. Grover, Lori Latowski Grover, Martina Mookadam, Lanyu Mi, Yu-Hui Chang, James Parish
Format: Article
Language:English
Published: SAGE Publishing 2019-11-01
Series:Journal of Primary Care & Community Health
Online Access:https://doi.org/10.1177/2150132719886951
id doaj-e34dd14e6ccc40789798f4b414802a12
record_format Article
spelling doaj-e34dd14e6ccc40789798f4b414802a122020-11-25T03:04:42ZengSAGE PublishingJournal of Primary Care & Community Health2150-13272019-11-011010.1177/2150132719886951Examining the Utility of a Novel Neurologic Test in Patients With Obstructive Sleep Apnea: A Pilot StudyMichael L. Grover0Lori Latowski Grover1Martina Mookadam2Lanyu Mi3Yu-Hui Chang4James Parish5Mayo Clinic, Scottsdale, AZ, USASouthern College of Optometry, Memphis, TN, USAMayo Clinic, Scottsdale, AZ, USAMayo Clinic, Scottsdale, AZ, USAMayo Clinic, Scottsdale, AZ, USAMayo Clinic, Scottsdale, AZ, USAPurpose: To test the association between participant King-Devick Test (KDT) times and obstructive sleep apnea (OSA) severity and evaluate for improvement after continuous positive airway pressure (CPAP) treatment. Methods: Study dates January 30 to July 31, 2018. Patients were referred for initial evaluation of sleep disordered breathing concerns. OSA severities were defined by Apnea Hypopnea Index (AHI) results, with ≥15 considered at least moderate OSA. The KDT is an objective physical measure of brain function. We estimated correlation between KDT time and AHI and compared mean KDT time between patients with and without moderate OSA. For the OSA subgroup, we evaluated for potential improvement in KDT after CPAP. Results: We enrolled 60 participants, of whom 35 (58.3%) had OSA with an AHI ≥15. Initial analyses noted no significant KDT time differences between patients based on OSA severity. However, after excluding 3 participants who had baseline neurologic illness, adjusted analyses demonstrated that mean KDT time was significantly prolonged for patients with moderate or greater OSA (AHI ≥15) as compared to those with mild or no sleep apnea (AHI <15); 63.4 seconds (95% CI 58.9-67.8) versus 55.7 seconds (95% CI 50.2-61.1), P = .03. CPAP-treated subjects demonstrated significantly improved KDT test times; 63.5 seconds mean pretreatment versus 55.6 posttreatment; −6.6 seconds mean difference, 95%CI (−12.0, −1.13), P = .02. Conclusion: Neurologic abnormalities in patients with OSA are potentially demonstrable utilizing this objective physical measure. Significant improvement is achieved in patients after CPAP treatment.https://doi.org/10.1177/2150132719886951
collection DOAJ
language English
format Article
sources DOAJ
author Michael L. Grover
Lori Latowski Grover
Martina Mookadam
Lanyu Mi
Yu-Hui Chang
James Parish
spellingShingle Michael L. Grover
Lori Latowski Grover
Martina Mookadam
Lanyu Mi
Yu-Hui Chang
James Parish
Examining the Utility of a Novel Neurologic Test in Patients With Obstructive Sleep Apnea: A Pilot Study
Journal of Primary Care & Community Health
author_facet Michael L. Grover
Lori Latowski Grover
Martina Mookadam
Lanyu Mi
Yu-Hui Chang
James Parish
author_sort Michael L. Grover
title Examining the Utility of a Novel Neurologic Test in Patients With Obstructive Sleep Apnea: A Pilot Study
title_short Examining the Utility of a Novel Neurologic Test in Patients With Obstructive Sleep Apnea: A Pilot Study
title_full Examining the Utility of a Novel Neurologic Test in Patients With Obstructive Sleep Apnea: A Pilot Study
title_fullStr Examining the Utility of a Novel Neurologic Test in Patients With Obstructive Sleep Apnea: A Pilot Study
title_full_unstemmed Examining the Utility of a Novel Neurologic Test in Patients With Obstructive Sleep Apnea: A Pilot Study
title_sort examining the utility of a novel neurologic test in patients with obstructive sleep apnea: a pilot study
publisher SAGE Publishing
series Journal of Primary Care & Community Health
issn 2150-1327
publishDate 2019-11-01
description Purpose: To test the association between participant King-Devick Test (KDT) times and obstructive sleep apnea (OSA) severity and evaluate for improvement after continuous positive airway pressure (CPAP) treatment. Methods: Study dates January 30 to July 31, 2018. Patients were referred for initial evaluation of sleep disordered breathing concerns. OSA severities were defined by Apnea Hypopnea Index (AHI) results, with ≥15 considered at least moderate OSA. The KDT is an objective physical measure of brain function. We estimated correlation between KDT time and AHI and compared mean KDT time between patients with and without moderate OSA. For the OSA subgroup, we evaluated for potential improvement in KDT after CPAP. Results: We enrolled 60 participants, of whom 35 (58.3%) had OSA with an AHI ≥15. Initial analyses noted no significant KDT time differences between patients based on OSA severity. However, after excluding 3 participants who had baseline neurologic illness, adjusted analyses demonstrated that mean KDT time was significantly prolonged for patients with moderate or greater OSA (AHI ≥15) as compared to those with mild or no sleep apnea (AHI <15); 63.4 seconds (95% CI 58.9-67.8) versus 55.7 seconds (95% CI 50.2-61.1), P = .03. CPAP-treated subjects demonstrated significantly improved KDT test times; 63.5 seconds mean pretreatment versus 55.6 posttreatment; −6.6 seconds mean difference, 95%CI (−12.0, −1.13), P = .02. Conclusion: Neurologic abnormalities in patients with OSA are potentially demonstrable utilizing this objective physical measure. Significant improvement is achieved in patients after CPAP treatment.
url https://doi.org/10.1177/2150132719886951
work_keys_str_mv AT michaellgrover examiningtheutilityofanovelneurologictestinpatientswithobstructivesleepapneaapilotstudy
AT lorilatowskigrover examiningtheutilityofanovelneurologictestinpatientswithobstructivesleepapneaapilotstudy
AT martinamookadam examiningtheutilityofanovelneurologictestinpatientswithobstructivesleepapneaapilotstudy
AT lanyumi examiningtheutilityofanovelneurologictestinpatientswithobstructivesleepapneaapilotstudy
AT yuhuichang examiningtheutilityofanovelneurologictestinpatientswithobstructivesleepapneaapilotstudy
AT jamesparish examiningtheutilityofanovelneurologictestinpatientswithobstructivesleepapneaapilotstudy
_version_ 1724680245121908736